19 Nov 2026, 09:10
Presentations—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 09:10 | Corporate Presentation - Bell Potter Healthcare Conference | Presentations | — | 03026 | |
| 18 Nov 2026, 09:05 | BLS Provides Update on UK Manufacturing | Company Update | — | 11001 | |
| 16 Nov 2026, 18:49 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 16 Nov 2026, 08:42 | To Present at Bell Potter Health Care Conference 19.11.2026 | Company Administration | — | 12008 | |
| 27 Oct 2026, 18:00 | Directors Change of Interest Notice X 2 | Director Interests | — | 02009 | |
| 26 Oct 2026, 18:13 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 23 Oct 2026, 17:01 | Letter to Shareholders re Annual General Meeting | Meetings & Governance | — | 08006, 16002 | |
| 23 Oct 2026, 16:48 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 21 Oct 2026, 08:56 | Q1 FY2027 Quarterly Activities Update | Presentations | MS | 03026, 19006 | |
| 15 Oct 2026, 09:19 | BLS Quarterly Activities Report September 2026 Revised | Quarterly Reports | MS | 19001, 19006 | |
| 15 Oct 2026, 08:28 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 13 Oct 2026, 08:59 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 9 Oct 2026, 14:39 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Oct 2026, 09:54 | AGM Date and Director Nominations | Meetings & Governance | — | 08006 | |
| 5 Oct 2026, 11:46 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 28 Sept 2026, 14:49 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 15 Sept 2026, 08:20 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 14 Sept 2026, 08:25 | Angus Walker Appointed Alternate Director to Edward Myer | Company Administration | — | 12001 | |
| 10 Sept 2026, 16:36 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 4 Sept 2026, 17:10 | S&P DJI Announces September 2026 Quarterly Rebalance | Other | MS | — | |
| 4 Sept 2026, 17:07 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 31 Aug 2026, 15:03 | Appendix 4G Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 12:51 | BLS FY2027 Guidance | Financial Results | MS | 03003, 03021 | |
| 31 Aug 2026, 12:44 | BLS Investor Presentation | Financial Results | MS | 03003, 03026 | |
| 31 Aug 2026, 12:37 | BLS FY2026 Results Announcement | Financial Results | MS | 03003, 14014 | |
| 31 Aug 2026, 12:36 | Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 Aug 2026, 11:51 | BLS FY2026 Results Webinar 2 September 2026 8am AEST | Presentations | — | 03027, 14014 | |
| 13 Aug 2026, 08:12 | Application for quotation of securities - BLS | Securities Administration | — | 06020 | |
| 30 July 2026, 16:59 | BLS to Present at Coffee Microcaps 31/7/2026 at 11.30 am | Company Administration | — | 12008 | |
| 30 July 2026, 08:57 | BLS Pharmaceuticals Investor Webinar Presentation | Presentations | MS | 03026 | |
| 29 July 2026, 14:46 | BLS Q4 FY2026 Results Investor Webinar | Presentations | — | 14014 | |
| 27 July 2026, 08:52 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 03027, 19004, 19009 | |
| 22 July 2026, 08:34 | Agreement with Trexapharm for Commercialisation of Trexavive | Company Update | — | 11001 | |
| 21 July 2026, 08:45 | BLS Strengthens Gobal Psychedelic Medicines Platform | Company Update | — | 11001 |